Anlon Healthcare P/E Ratio
Anlon Healthcare P/E ratio. Anlon Healthcare (AHCL) P/E ratio is 33.0 (High), EPS (TTM) ₹6.11, current price ₹24.97 on NSE vs historical average P/E of 14.51 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Also explore Anlon Healthcare share price performance to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
AHCL P/E Ratio — Valuation Signal & Historical Context
Anlon Healthcare P/E 33.0 vs historical average 14.51, range 14.51–14.51 — signal: Overvalued. Check Anlon Healthcare market cap to track the company's total market size over time.
- Stock appears overvalued with PE of 33.0, suggesting caution for new investments
- Current PE is 127.4% above historical average
- Trading at discount to sector average PE of 52.27
Anlon Healthcare P/E Ratio Historical Trend
AHCL annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 33.0 vs historical average 14.51. For live price, revenue and the complete fundamental profile, see AHCL screener.
AHCL Historical P/E Ratio — EPS, Year-End Price & Valuation
Anlon Healthcare annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 14.51 | 7.35 | ₹106.64 | NSE | Low |
AHCL vs Healthcare Peers — P/E Ratio Comparison
Anlon Healthcare P/E 33.0 vs Healthcare average 52.27, median 29.4 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |